Arcadia Biosciences Inc (RKDA)
3.00
-0.27
(-8.26%)
USD |
NASDAQ |
May 20, 09:43
Arcadia Biosciences Research and Development Expense (Quarterly): 0.272M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.272M |
December 31, 2023 | 0.332M |
September 30, 2023 | 0.305M |
June 30, 2023 | 0.391M |
March 31, 2023 | 0.359M |
December 31, 2022 | 0.50M |
September 30, 2022 | 0.255M |
June 30, 2022 | 0.359M |
March 31, 2022 | 0.395M |
December 31, 2021 | 0.561M |
September 30, 2021 | 1.038M |
June 30, 2021 | 1.131M |
March 31, 2021 | 1.159M |
December 31, 2020 | 1.961M |
September 30, 2020 | 1.762M |
June 30, 2020 | 1.993M |
March 31, 2020 | 2.244M |
December 31, 2019 | 1.711M |
September 30, 2019 | 1.931M |
June 30, 2019 | 1.95M |
March 31, 2019 | 1.505M |
Date | Value |
---|---|
December 31, 2018 | 1.545M |
September 30, 2018 | 1.334M |
June 30, 2018 | 1.794M |
March 31, 2018 | 1.396M |
December 31, 2017 | 2.166M |
September 30, 2017 | 1.749M |
June 30, 2017 | 1.669M |
March 31, 2017 | 1.823M |
December 31, 2016 | 1.99M |
September 30, 2016 | 2.255M |
June 30, 2016 | 2.216M |
March 31, 2016 | 2.202M |
December 31, 2015 | 1.869M |
September 30, 2015 | 3.179M |
June 30, 2015 | 2.086M |
March 31, 2015 | 1.832M |
December 31, 2014 | 2.07M |
September 30, 2014 | 3.684M |
June 30, 2014 | 2.275M |
March 31, 2014 | 1.983M |
December 31, 2013 | 2.185M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.255M
Minimum
Sep 2022
2.244M
Maximum
Mar 2020
1.030M
Average
0.7995M
Median